WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004007538) MOLECULAR ANTIGEN ARRAYS USING A VIRUS LIKE PARTICLE DERIVED FROM THE AP205 COAT PROTEIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/007538    International Application No.:    PCT/EP2003/007572
Publication Date: 22.01.2004 International Filing Date: 14.07.2003
Chapter 2 Demand Filed:    22.01.2004    
IPC:
A61K 39/00 (2006.01), A61K 39/35 (2006.01), C07K 14/08 (2006.01), C07K 14/54 (2006.01), C07K 16/24 (2006.01), C07K 16/40 (2006.01), C12N 7/04 (2006.01)
Applicants: CYTOS BIOTECHNOLOGY AG [CH/CH]; Wagistrasse 21, CH-8952 Schlieren (CH) (For All Designated States Except US).
BACHMANN, Martin, F. [CH/CH]; (CH) (For US Only).
TISSOT, Alain [CH/CH]; (CH) (For US Only).
PUMPENS, Paul [LV/LV]; (LV) (For US Only).
CIELENS, Indulis [LV/LV]; (LV) (For US Only).
RENHOFA, Regina [LV/LV]; (LV) (For US Only)
Inventors: BACHMANN, Martin, F.; (CH).
TISSOT, Alain; (CH).
PUMPENS, Paul; (LV).
CIELENS, Indulis; (LV).
RENHOFA, Regina; (LV)
Agent: WICHMANN, Hendrik; Isenbruck Bösl Hörschler Wichmann Huhn, Postfach 86 08 80, 81635 München (DE)
Priority Data:
60/396,126 17.07.2002 US
Title (EN) MOLECULAR ANTIGEN ARRAYS USING A VIRUS LIKE PARTICLE DERIVED FROM THE AP205 COAT PROTEIN
(FR) RESEAUX D'ANTIGENES MOLECULAIRES
Abstract: front page image
(EN)The present invention provides a composition comprising an AP205 virus like particle (VLP) and an antigen. The invention also provides a process for producing an antigen or antigenic determinant bound to AP205 VLP. AP205 VLP bound to an antigen is useful in the production of compositions for inducing immune responses that are useful for the prevention or treatment of diseases, disorders or conditions including infectious diseases, allergies, cancer, drug addiction, poisoning and to efficiently induce self-specific immune responses, in particular antibody responses.
(FR)La présente invention concerne une composition comprenant une particule pseudovirale (VLP) AP205 et un antigène. L'invention concerne également un procédé de production d'un antigène ou d'un déterminant antigénique lié à la VLP AP205. Cette VLP AP205 liée à un antigène est utile pour produire des compositions destinées à induire des réponses immunitaires, utiles pour prévenir ou traiter des maladies, des troubles ou des états, notamment des maladies infectieuses, des allergies, un cancer, une toxicomanie ou un empoisonnement, et pour induire de façon efficace des réponses immunitaires auto-spécifiques, en particulier des réponses anticorps.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)